LATEST ISSUE
March/April 2021
An increasing number of stakeholders rely on health economics and outcomes research (HEOR) evidence to assess relative value, to weigh treatment choices, and to help them target possible patient outcomes under finite budgets. Clinicians, payers, patients, governments, health ministries, and other stakeholders need access to up-to-date HEOR information to inform their understanding of the therapeutic and economic value of a given product in a real-world clinical practice environment and to help clarify their decision making.
Vol. 7 | No. 1 - Supplement
March 2021
Valuing Future Alzheimer's Disease Treatments: The Need for a Holistic Approach
VOL. 6, NO. 6
November/December 2020
Challenges in Precision Medicine: Aiming to Align Data, Value, and Costs
VOL. 6 NO. 1